Wildcat Capital Management, LLC Sorrento Therapeutics, Inc. Transaction History

Wildcat Capital Management, LLC

  • $204 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$2.05 - $2.69 $852,318 - $1.12 Million
-415,765 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$4.5 - $9.95 $5.95 Million - $13.2 Million
-1,322,467 Reduced 76.08%
415,765 $2.14 Million
Q4 2017

Feb 14, 2018
SELL
$1.75 - $3.8 $1.86 Million - $4.03 Million
-1,061,558 Reduced 37.92%
1,738,232 $6.61 Million
Q2 2017

Aug 14, 2017
BUY
N/A
2,799,790
2,799,790 $5.6 Million

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Wildcat Capital Management, LLC Portfolio

Follow Wildcat Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wildcat Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wildcat Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email